INmune Bio | 8-K: Current report
INmune Bio | DEF 14A: Definitive information statements
INmune Bio | 8-K: Current report
INmune Bio | 4: Statement of changes in beneficial ownership of securities-Director ALLEN MARCIA
INmune Bio | 4: Statement of changes in beneficial ownership of securities-Director Schroeder Timothy j
INmune Bio | 4: Statement of changes in beneficial ownership of securities-Officer Tesi Raymond Joseph
INmune Bio | 4: Statement of changes in beneficial ownership of securities-Officer Moss David J
INmune Bio | 4: Statement of changes in beneficial ownership of securities-Director Ganjei James Kelly
INmune Bio | 4: Statement of changes in beneficial ownership of securities-Director Juda Scott
INmune Bio | 4: Statement of changes in beneficial ownership of securities-Officer Lowdell Mark William
INmune Bio | 4: Statement of changes in beneficial ownership of securities-Director Baracchini Edgardo Jr
INmune Bio | 8-K: Current report
INmune Bio | 8-K: Current report
INmune Bio | 10-Q: Quarterly report
INmune Bio | S-3: Registration statement for specified transactions by certain issuers
INmune Bio | 8-K: Current report
INmune Bio | 8-K: Current report
INmune Bio | 424B5: Prospectus
INmune Bio | 8-K: Current report
INmune Bio | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Moss David J
No Data